Cargando…
Emodin Induced Necroptosis and Inhibited Glycolysis in the Renal Cancer Cells by Enhancing ROS
Renal cell carcinoma (RCC) is a tumor with unpredictable presentation and poor clinical outcome. RCC is always resistant to chemotherapy and radiation, and weakly sensitive to immunotherapeutic agents. Therefore, novel agents and approaches are urgently needed for the treatment of RCC. Emodin, an an...
Autores principales: | Wang, Ke-jie, Meng, Xiang-yu, Chen, Jun-feng, Wang, Kai-yun, Zhou, Cheng, Yu, Rui, Ma, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837784/ https://www.ncbi.nlm.nih.gov/pubmed/33532038 http://dx.doi.org/10.1155/2021/8840590 |
Ejemplares similares
-
Emodin enhances osteogenesis and inhibits adipogenesis
por: Yang, Feng, et al.
Publicado: (2014) -
Emodin Augments Cisplatin Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells via ROS-Dependent MRP1 Downregulation
por: Ma, Jun, et al.
Publicado: (2014) -
Up-Regulation of RIP3 Alleviates Prostate Cancer Progression by Activation of RIP3/MLKL Signaling Pathway and Induction of Necroptosis
por: Wang, Ke-jie, et al.
Publicado: (2020) -
Osthole induces necroptosis via ROS overproduction in glioma cells
por: Huangfu, Mengjie, et al.
Publicado: (2021) -
Sinularin exerts anti-tumor effects against human renal cancer cells relies on the generation of ROS
por: Ma, Qi, et al.
Publicado: (2019)